Cytokinetics INC DEF 14A proxy statements
Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.
NASDAQ
CYTK
Cytokinetics INCCytokinetics, Inc. has issued its 2026 Proxy Statement detailing proposals for the upcoming Annual Meeting of Stockholders on May 27, 2026.
NASDAQ
CYTK
Cytokinetics INCDEF: Cytokinetics Seeks Stockholder Approval for Increased Share Authorization and Equity Plan Amendments
Cytokinetics is asking stockholders to approve proposals at its upcoming annual meeting, including increasing authorized shares and amending its equity incentive plan.
NASDAQ
CYTK
Cytokinetics INCCytokinetics has filed its proxy statement for the 2024 Annual Meeting of Stockholders, outlining proposals for director elections, an employee stock purchase plan amendment, ratification of auditors, and an advisory vote on executive compensation.